CliffBio
small molecule

FLECTOR

DICLOFENAC EPOLAMINE

Loss of exclusivity—loss of exclusivity
CompanyIBSA Institut Biochimique →See this company's full patent-cliff portfolio

Drug detail

Brand nameFLECTOR
Active ingredientDICLOFENAC EPOLAMINE
Strength1.3%
Dosage formSYSTEM
RouteTOPICAL
ModalitySmall molecule
FDA approvalJanuary 2007
Marketing statusRX

More from IBSA Institut Biochimique

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

FLECTOR patent cliff — loss of exclusivity — | CliffBio